News & Views
Bill Burns Appointed as Non Executive Director
May 07 2010
Shire plc (Dublin) a specialty biopharmaceutical company has appointed Bill Burns to its Board as a Non Executive Director with immediate effect. Mr Burns has also been appointed a member of Shire’s Remuneration Committee. Mr Burns has a long and distinguished career in the global pharmaceuticals industry, most recently as CEO of Roche’s Pharmaceuticals Division and as a member of the Roche Group Corporate Executive Committee. He was involved in the acquisition and privatisation of Genentech, led the integration of Boehringer Mannheim Therapeutics and played a lead role in the negotiations resulting in Roche becoming a majority owner of Chugai in Japan. Following retirement in January this year, he has since been appointed to the Board of Directors of Roche Holdings Ltd and is a Board member of bothChugai Pharmaceuticals and of Genentech Inc.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE